George Yancopoulos, President and Chief Scientific at REGENERON PHARMACEUTICALS, INC. (REGN), sold 311,585 shares at $600.06 ($60.0M) on 2021-08-05, disclosed to the SEC on 2021-08-06.
Open-market sale of $60.0M REGN by President and Chief Scientific. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 211,585 | $0 | 0.0% |
| 2 | $600.06 | 50,000 | $30.0M | 50.0% |
| 3 | $600.06 | 50,000 | $30.0M | 50.0% |
| Total | $192.58 avg | 311,585 | $60.0M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |